Cognition Therapeutics Elucidates Genetic Mutation that Protects Against Alzheimer’s Disease
19 oct. 2020 08h00 HE
|
Cognition Therapeutics, Inc.
Pittsburgh, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company developing drugs that treat neurodegenerative disorders by regulating cellular...